BioXcel Therapeutics, Inc. (BTAI)
NASDAQ · Healthcare
BioXcel Therapeutics, Inc. Balance Sheet 2022–2025
| Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | |
|---|---|---|---|---|
| Assets | ||||
| Total Assets | 44.9M | 38.3M | 73.7M | 205.9M |
| Cash & Equivalents | 28.4M | 29.9M | 65.2M | 193.7M |
| Liabilities | ||||
| Total Liabilities | 140.4M | 131.4M | 130.2M | 129.1M |
| Long-Term Debt | 109.6M | 102.5M | 100.6M | 93.1M |
| Equity | ||||
| Shareholders' Equity | -95.5M | -93.1M | -56.5M | 76.8M |
BioXcel Therapeutics, Inc. Balance Sheet — FAQ
BioXcel Therapeutics, Inc. (BTAI) balance sheet over the last 4 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see BTAI's balance sheet history?
The chart and table above show BioXcel Therapeutics, Inc.'s balance sheet by year and by quarter, including the growth rate.